AI Article Synopsis
- The uroflow examination is a highly reliable and noninvasive way to evaluate bladder outflow obstruction.
- Errors can occur due to issues with the uroflowmeter, patient-related factors like psychological inhibition, or variations in bladder physiology, like intravesical volume.
- In some situations, further testing, like pressure-flow studies or simple cystometry, may be necessary for a comprehensive assessment.
Article Abstract
The uroflow examination is the most accurate, physiologic, and noninvasive method of assessing bladder outflow obstruction. The examiner must be aware of the errors that may arise from problems inherent in the uroflowmeter, in the patient (such as psychological inhibition), or in bladder physiology (such as the influence of intravesical volume). Additional tests such as pressure-flow studies or simple cystometry are required in certain cases.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study.
EClinicalMedicine
December 2024
Department of Pathology and Genetics, Laboratory of Cancer Medical Science, Hokuto Hospital, Obihiro, Hokkaido, Japan.
Background: Pancreatic cancer is highly aggressive and has a low survival rate primarily due to late-stage diagnosis and the lack of effective early detection methods. We introduce here a novel, noninvasive urinary extracellular vesicle miRNA-based assay for the detection of pancreatic cancer from early to late stages.
Methods: From September 2019 to July 2023, Urine samples were collected from patients with pancreatic cancer (n = 153) from five distinct sites (Hokuto Hospital, Kawasaki Medical School Hospital, National Cancer Center Hospital, Kagoshima University Hospital, and Kumagaya General Hospital) and non-cancer participants (n = 309) from two separate sites (Hokuto Hospital and Omiya City Clinic).
Five-year sustainability of a de-implementation strategy to reduce inappropriate use of catheters: a multicentre, mixed-methods study.
EClinicalMedicine
September 2024
Amsterdam UMC, University of Amsterdam, Department of Internal Medicine-Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam Public Health, the Netherlands.
Background: The use of peripheral intravenous catheters (PIVCs) contributes to healthcare-associated infections. In 2017, we implemented a multifaceted de-implementation strategy that successfully reduced the inappropriate use of catheters in seven hospitals in the Netherlands (RICAT-1 study). Five years later, we investigated the sustainability of this strategy and the contributing factors.
View Article and Find Full Text PDF[Detection and interpretation of PD-L1 in urologic neoplasms].
Zhonghua Bing Li Xue Za Zhi
January 2025
Department of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University Health Science Center, Beijing100191, China.
Immune checkpoint inhibitors targeting PD-1/PD-L1 are gradually being applied in the treatment of advanced urinary system tumors. Immunohistochemical analysis of PD-L1 expression is the most popular method for screening suitable patients for immunotherapy and predicting therapeutic efficacy. The current application status of PD-L1 detection for urinary system tumors (mainly urothelial carcinoma), methods of the different antibody tests and the precautions, challenges and solutions in the interpretation of immunostaining were summarized in this review.
View Article and Find Full Text PDFNovel technologies for the diagnosis of urinary tract infections.
J Clin Microbiol
January 2025
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Urinary tract infections (UTIs) impose a substantial burden on patient quality of life and urine testing accounts for the majority of workload in many clinical microbiology laboratories. Traditional UTI diagnosis relies on symptoms, urinalysis, and culture which are interpreted based on historical guidelines. This approach, while foundational, presents limitations, particularly in complex cases.
View Article and Find Full Text PDFEfficacy and safety of sublingual buprenorphine in managing acute postoperative pain - A systematic review.
J Anaesthesiol Clin Pharmacol
July 2024
Department of Pediatric Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Sublingual (SL) buprenorphine has been used as a modality of managing acute postoperative pain in many studies. This systematic review aimed to investigate the safety and efficacy of SL buprenorphine as an analgesic for various surgeries. After registering the protocol with PROSPERO, we searched PubMed, Cochrane Library, and Ovid databases with relevant keywords.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!